［3］Tulloh R. Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension［J］.Paediatr Drugs, 2009, 11(2):115-128.
［4］Sakuma M, Shirato K. Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension［J］.Nippon Rinsho, 2008, 66(11):2157-2161.
［5］Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study［J］.Circulation, 2005, 111（24）:3274-3280.
［6］Raposo-Sonnenfeld I, Otero-Gonzalez I, Blanco-Aparici M, Ferrer-Barba A, Medranolopez C. Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome［J］.Rev Esp Cardiol, 2007, 60(4):366-372.
［8］Haworth SG, Hislop AA.Treatment and survival in children with pulmonary arterial hypertension:the UK Pulmonary Hypertension Service for Children 2001-2006［J］.Heart 2009, 95（4）:312-317.
［9］Krishnan U, Krishnan S, Gewitz M. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies［J］.Pediatr Cardiol, 2008, 29(6):1082-1086.
［10］Kovacikova L, Zahorec M, Nosal M.Sildenafil as a pulmonary vasodilator after repair of congenital heart disease［J］.Bratisl Lek Listy, 2007,108(10-11):453-454.
［11］Peiravian F, Amirghofran AA, Borzouee M, Ajami GH, Sabri MR, Kolaee S. Oral sildenafil to control pulmonary hypertension after congenital heart surgery［J］.Asian Cardiovasc Thorac Ann, 2007,15（2）:113-117 .
［13］Raja SG, Macarthur KJ, Pollock JC. Is sildenafil effective for treating pulmonary hypertension after pediatric heart surgery?［J］.Interact Cardiovasc Thorac Surg , 2006, 5（1）:52-54.
［14］Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery［J］.Intensive Care Med, 2003, 29（11）:1996-2003.
［15］Schulze-Neick I, Hartenstein P, Li J, Stiller B, Naqdvman N, Hubler M, et al. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease［J］.Circulation, 2003,108 (Suppl 1):II167-173.
［16］Kothari SS, Duggal B. Chronic oral sildenafil therapy in severe pulmonary artery hypertension［J］.Indian Heart J, 2002, 54（4）:404-409.
［17］Latini G, Del Vecchio A, De Felice C, Verrotti A, Bossone E.Persistent pulmonary hypertension of the newborn: therapeutical approach［J］.Mini Rev Med Chem, 2008, 8(14):1507-1513.
［18］Juliana AE, Abbad FC. Severe persistent pulmonary hypertension of the new born in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil［J］.Eur J Pediatr, 2005, 164（10）:626-629.
［19］Baquero H, Soliz A, Neira F, Veneqas ME, Sola A.Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study［J］.Pediatrics, 2006,117(4):1077-1083.
［20］Shah PS, Ohlsson A. Sildenafil for pulmonary hypertension in neonates［J］.Cochrane Database Syst Rev, 2007, 18 (3):CD005494.
［21］Shafig N, Reddy S, Pandhi P. Sildenafil for pulmonary hypertension: need for evidence generation［J］.Int J Clin Pharmacol Ther, 2008, 46(12):644-651.
［22］Saxena A, Juneja R, Ramakrishnan S. Drug therapy of cardiac diseases in children［J］.Indian Pediatr, 2009, 46（4）:310-338.
［23］Raja SG, Danton MD, MacArthur KJ, Pollock JC. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects［J］.J Cardiothorac Vasc Anesth, 2007, 21(2):203-207.
［24］de Souza AH, Cabral LM, Huf G.Current practices in the use of sildenafil for pulmonary arterial hypertension in Brazilian hospitals［J］.BMC Res Notes, 2009, 2(30):1756-1761.
［25］Nahata MC, Morosco RS, Bradv MT.Extemporaneous sildenafil citrate oral suspensions for the treatment of pulmonary hypertension in children［J］.Am J Health Syst Pharm, 2006, 63（3）:254-257.
